220 related articles for article (PubMed ID: 22039670)
21. Plasma cell leukemia: update on biology and therapy.
Mina R; D'Agostino M; Cerrato C; Gay F; Palumbo A
Leuk Lymphoma; 2017 Jul; 58(7):1538-1547. PubMed ID: 27819179
[TBL] [Abstract][Full Text] [Related]
22. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
Yeh YA; Pappas AA; Flick JT; Butch AW
Ann Clin Lab Sci; 2000 Jul; 30(3):283-8. PubMed ID: 10945569
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcomes of patients with plasma cell leukemia in the era of novel therapies and hematopoietic stem cell transplantation strategies: a single-institution experience.
Lebovic D; Zhang L; Alsina M; Nishihori T; Shain KH; Sullivan D; Ochoa-Bayona JL; Kharfan-Dabaja MA; Baz R
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):507-11. PubMed ID: 21813352
[TBL] [Abstract][Full Text] [Related]
24. [A primitive plasma cell leukemia with immunoglobulin (Ig) E].
Rachidi M; Lazarian G; Letestu R; Lusina D; Desbene C; Vidal V; Eclache V; Baran-Marszak F; Cymbalista F; Fleury C
Ann Biol Clin (Paris); 2019 Oct; 77(5):557-561. PubMed ID: 31512579
[TBL] [Abstract][Full Text] [Related]
25. Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation.
Gemmel C; Cremer FW; Weis M; Witzens M; Moldenhauer G; Koniczek KH; Imbach U; Ho AD; Moos M; Goldschmidt H
Ann Hematol; 2002 Feb; 81(2):119-23. PubMed ID: 11907796
[TBL] [Abstract][Full Text] [Related]
26. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study.
Guan J; Ma J; Chen B
Hematology; 2023 Dec; 28(1):2254556. PubMed ID: 37732631
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome.
Todoerti K; Agnelli L; Fabris S; Lionetti M; Tuana G; Mosca L; Lombardi L; Grieco V; Bianchino G; D'Auria F; Statuto T; Mazzoccoli C; De Luca L; Petrucci MT; Morabito F; Offidani M; Di Raimondo F; Falcone A; Omede' P; Tassone P; Boccadoro M; Palumbo A; Neri A; Musto P
Clin Cancer Res; 2013 Jun; 19(12):3247-58. PubMed ID: 23599371
[TBL] [Abstract][Full Text] [Related]
28. Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia.
Chang H; Qi X; Yeung J; Reece D; Xu W; Patterson B
Leuk Res; 2009 Feb; 33(2):259-62. PubMed ID: 18676019
[TBL] [Abstract][Full Text] [Related]
29. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.
Fernández de Larrea C; Kyle RA; Durie BG; Ludwig H; Usmani S; Vesole DH; Hajek R; San Miguel JF; Sezer O; Sonneveld P; Kumar SK; Mahindra A; Comenzo R; Palumbo A; Mazumber A; Anderson KC; Richardson PG; Badros AZ; Caers J; Cavo M; LeLeu X; Dimopoulos MA; Chim CS; Schots R; Noeul A; Fantl D; Mellqvist UH; Landgren O; Chanan-Khan A; Moreau P; Fonseca R; Merlini G; Lahuerta JJ; Bladé J; Orlowski RZ; Shah JJ;
Leukemia; 2013 Apr; 27(4):780-91. PubMed ID: 23288300
[TBL] [Abstract][Full Text] [Related]
30. Plasma cell leukemia: a retrospective study of 10 cases.
Agarwal AD; Brahmbhatt BS; Parikh BP; Shah MJ
Indian J Cancer; 2014; 51(1):18-9. PubMed ID: 24947090
[TBL] [Abstract][Full Text] [Related]
31. Plasma cell leukemia.
Albarracin F; Fonseca R
Blood Rev; 2011 May; 25(3):107-12. PubMed ID: 21295388
[TBL] [Abstract][Full Text] [Related]
32. Plasma cell leukemia.
Hayman SR; Fonseca R
Curr Treat Options Oncol; 2001 Jun; 2(3):205-16. PubMed ID: 12057120
[TBL] [Abstract][Full Text] [Related]
33. A retrospective analysis of thirty-one cases of plasma cell leukemia from a single center in China.
Peijing Q; Yan X; Yafei W; Dehui Z; Zengjun L; Junyuan Q; Yaozhong Z; Lugui Q
Acta Haematol; 2009; 121(1):47-51. PubMed ID: 19339770
[TBL] [Abstract][Full Text] [Related]
34. Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation.
Johnson MR; Del Carpio-Jayo D; Lin P; Giralt S; Anderlini P; Champlin RE; Khouri IF; Vadhan-Raj S; Medeiros LJ; Bueso-Ramos CE
Ann Diagn Pathol; 2006 Oct; 10(5):263-8. PubMed ID: 16979517
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of bortezomib in patients with plasma cell leukemia.
Musto P; Rossini F; Gay F; Pitini V; Guglielmelli T; D'Arena G; Ferrara F; Filardi N; Guariglia R; Palumbo A; ; ;
Cancer; 2007 Jun; 109(11):2285-90. PubMed ID: 17469169
[TBL] [Abstract][Full Text] [Related]
36. Plasma cell leukemia--a case report.
Badhe BA; Basu D; Toi PCh; Dutta TK; Ghotekar LH
Indian J Pathol Microbiol; 2003 Jul; 46(3):484-7. PubMed ID: 15025318
[TBL] [Abstract][Full Text] [Related]
37. Primary plasma cell leukemia in the era of new drugs: has something changed?
Musto P; Pagano L; Petrucci MT; Morabito F; Caravita T; Di Raimondo F; Baldini L; Tosi P; Bringhen S; Offidani M; Omede' P; Neri A; D'Auria F; Bochicchio GB; Cavo M; Boccadoro M; Palumbo A
Crit Rev Oncol Hematol; 2012 May; 82(2):141-9. PubMed ID: 21719304
[TBL] [Abstract][Full Text] [Related]
38. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
39. Acquired del(9)(p22.3) in a primary plasma cell leukemia.
Achkar WA; Wafa A; Aljapawe A; Othman MA; Alhourani E; Liehr T
Mol Cytogenet; 2013 Aug; 6(1):33. PubMed ID: 23985162
[TBL] [Abstract][Full Text] [Related]
40. Plasma cell leukemia masquerading as ALL-L3--a case report.
Tripathy K; Gouda KP; Chakrabarty S; Das AK; Mohanty R
Indian J Pathol Microbiol; 2005 Apr; 48(2):221-3. PubMed ID: 16758674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
